Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

BACKGROUND: Treatment for major depressive disorder (MDD) is imprecise and often involves trial-and-error to determine the most effective approach. To facilitate optimal treatment selection and inform timely adjustment, the current study investigated whether neurocognitive variables could predict an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Psychol Med
Autors principals: Ang, Yuen-Siang, Bruder, Gerard E., Keilp, John G., Rutherford, Ashleigh, Alschuler, Daniel M., Pechtel, Pia, Webb, Christian A., Carmody, Thomas, Fava, Maurizio, Cusin, Cristina, McGrath, Patrick J., Weissman, Myrna, Parsey, Ramin, Oquendo, Maria A., McInnis, Melvin G., Cooper, Crystal M., Deldin, Patricia, Trivedi, Madhukar H., Pizzagalli, Diego A.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613805/
https://ncbi.nlm.nih.gov/pubmed/33213541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0033291720004286
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars